P13: Aquaporins Function as a Novel Therapeutic Strategy for a Variety of Cerebral Disorders

Authors

  • Modarres Mousavi, Mostafa a. Shefa Neuroscience Research Center, Khatam Alanbia Hospital, Tehran, Iran. b. Department of Nanobiotechnology, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran
  • Najmi, Zeinab Shefa Neuroscience Research Center, Khatam Alanbia Hospital, Tehran, Iran
Abstract:

This article doesn't have abstract

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

the effectiveness of strategy-based instruction in teaching english as a second or foreign language: a meta-analysis of experimental studies

a large number of single research studies on the effects of strategy-based instruction (sbi) in teaching english as a foreign or second language has been conducted so far. however, the lack of a comprehensive meta-analysis targeting the effectiveness of english language sbi is observed. moreover, the findings of experimental studies regarding the context of the english language, proficiency lev...

Inhibition of semaphorin as a novel strategy for therapeutic angiogenesis.

RATIONALE The axon-guiding molecules known as semaphorins and their receptors (plexins) regulate the vascular pattern and play an important role in the development of vascular network during embryogenesis. Semaphorin (Sema)3E is one of the class 3 semaphorins, and plexinD1 is known to be its receptor. Although these molecules have a role in embryonic vascular development, it remains unclear whe...

full text

Utilizing TH9 cells as a novel therapeutic strategy for malignancies

TH9 cells join the ever-growing list of CD4+ T helper subsets and primarily mediate anti-parasite immune responses. We have recently demonstrated that tumor-specific TH9 cells induce a CCL20-CCR6-dependent regulation of DCs while stimulating CD8+ T cell-mediated antitumor immunity. These findings offer a novel immunotherapeutic strategy against cancer.

full text

Imatinib as a novel therapeutic approach for fibrotic disorders.

Imatinib mesylate is a small molecule that binds to the ATPbinding pocket of Abelson kinase (c-Abl) and blocks efficiently its tyrosine kinase activity. c-Abl is an important downstream signalling molecule of TGF[1]. The importance of c-Abl for the pro-fibrotic effects of TGFis emphasized by the observation that the induction of extracellular matrix proteins by TGFis strongly decreased in cells...

full text

Lead Tetraacetatelchromic Anhydride Combination as a Novel Reagent for the Selective Oxidation of Methylene Dioxide Function

Pb(OAc) /Cr0 combination was found to be able to oxidize methylene dioxide function in the presence of diphenylmethane moiety

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 6  issue 3

pages  40- 40

publication date 2018-07

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

No Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023